{
    "Trade/Device Name(s)": [
        "VisuLizeTM Factor VIII Antigen Kit"
    ],
    "Submitter Information": "Affinity Biologicals Inc.",
    "510(k) Number": "K052825",
    "Predicate Device Reference 510(k) Number(s)": [
        "K981038"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGP"
    ],
    "Summary Letter Date": "January 20, 2006",
    "Summary Letter Received Date": "December 6, 2005",
    "Submission Date": "December 5, 2005",
    "Regulation Number(s)": [
        "21 CFR 864.7290"
    ],
    "Regulation Name(s)": [
        "Factor deficiency test"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Factor VIII antigen"
    ],
    "Specimen Type(s)": [
        "Human plasma",
        "Factor VIII concentrates"
    ],
    "Specimen Container(s)": [
        "3.2% buffered citrate tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immuno-sorbent assay (ELISA)",
        "Double antibody assay"
    ],
    "Methodologies": [
        "Sandwich ELISA",
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for VisuLizeTM Factor VIII Antigen Kit, an ELISA-based quantitative assay for Factor VIII antigen in plasma and concentrates.",
    "Indications for Use Summary": "Intended for use as an in vitro diagnostic assay for the quantitative determination of Factor VIII antigen in human plasma samples and Factor VIII concentrates using a double antibody ELISA.",
    "fda_folder": "Hematology"
}